NCT00000412View on ClinicalTrials.gov

Osteoporosis Prevention After Heart Transplant

PHASE3CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

September 30, 1997

Primary Completion Date

April 30, 2002

Study Completion Date

April 30, 2002

Conditions
OsteoporosisCardiac Transplantation
Interventions
DRUG

Alendronate

DRUG

Calcitriol

DRUG

Placebo Alendronate

DRUG

Placebo Calcitriol

Trial Locations (2)

10032

Columbai University Medical Center, New York

Columbia University Medical Center, New York

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Columbia University

OTHER

NCT00000412 - Osteoporosis Prevention After Heart Transplant | Biotech Hunter | Biotech Hunter